Neutra Corp. (OTC:NTRR) flourished Monday, on news generated by one of its subsidiaries.
Sugarland, Texas-based VIVIS Corp. is reportedly gearing up for the market release of a new transdermal, hemp-based sports cream it says will prove popular with amateur athletes and others seeking relief after tough workouts and performances.
“The announcement,” said Monday’s news release, “is the latest in a series of bold initiatives Neutra undertook earlier this year to grab a share of a market analysts predict will hit $11 billion by 2026.”
Said Neutra CEO Sydney Jim, “We’re now seeing the positive payoff of hiring a dedicated sports medicine advisor earlier this year. Our goal with that hire was to develop hemp-based CBD (cannabidiol) products geared to the expanding sports market.
As more people participate in sports or exercise, many experience some type of discomfort. While some types of pain may require professional help, says the release, most discomfort can be treated in other ways, such as through creams and topical. This represents a sizable potential market for VIVIS’s upcoming hemp-based sports cream.
Shares galloped 50% early Monday afternoon to nine-100ths of a cent, on volume topping 11.1 million shares.